Skip to main content
OpenTrials

Clinical trial condition

Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

Explore clinical trials studying Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma. Study availability and eligibility vary by location and protocol.

6 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma trial results

Recruiting

A Study to Evaluate MK-1045 (CN201) in Participants With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (MK-1045-001/CN201-101)

NCT06189391

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations
  • Fifth Medical Center of PLA General Hospital ( Site 0005) Beijing, Beijing Municipality, China
  • Beijing Cancer hospital ( Site 0001) Beijing, Beijing Municipality, China
  • The First Affiliated Hospital of Xiamen University ( Site 0011) Xiameng, Fujian, China
  • Sun Yat-Sen University Cancer Center ( Site 0003) Guangzhou, Guangdong, China
View all 15 locations
View Trial Details
Completed

Study of Capivasertib in Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

NCT05008055

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
Locations
  • Research Site Duarte, California, United States
  • Research Site Los Angeles, California, United States
  • Research Site Houston, Texas, United States
  • Research Site Victoria, British Columbia, Canada
View all 17 locations
View Trial Details

Related conditions